Profile of patients with hypertension included in a cohort with HIV/AIDS in the state of pernambuco, Brazil;Perfil dos pacientes com hipertensão arterial incluídos em uma coorte com HIV/AIDS em pernambuco, Brasil

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 5, 2010, Pages 640-647

  De Arruda Júnior, Evanizio Roque ^a   Lacerda, Heloisa Ramos ^b,c   Moura, Líbia Cristina Rocha Vilela ^b   De Fátima, Maria ^e   De Albuquerque, Pessoa Militão ^b,d   De Barros Miranda Filho, Demócrito ^b   Diniz, George Tadeu Nunes ^d   De Albuquerque, Valéria Maria Gonçalves ^c   Amaral, Josefina Cláudia Zirpoli ^b   Monteiro, Verônica Soares ^c   De Arraes Ximenes, Ricardo Alencar ^b,c  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e NONE

Author keywords

Acquired immunodeficiency syndrome (AIDS); Antihypertensive agents; HIV: life style; Hypertension prevention control; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; BRAZIL; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG USE; FAMILY HISTORY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; WAIST CIRCUMFERENCE;

EID: 78651469120     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2010005000138     Document Type: Article

References (26)

1. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. The Lancet. 2008;372(9635):293-9.
2. Dihel LA, Dias JR, Paes AC, Thomazini MC, Garcia LR, Cinagawa E, et al. Prevalência da lipodistrofia associada ao HIV em pacientes ambulatoriais brasileiros: relação com síndrome metabólica e fatores de risco cardiovascular. Arq Bras Endocrinol Metabol. 2008;52(4):658-67.
3. Chow DC, Souza SA, Chen R, Richmond-Crum SM, Grandinetti A, Shikuma C. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin Trials. 2003;4(6):411-6.
4. Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens. 2008;26(11):2126-33.
5. Bergersen BM, Sandvik L, Bruun JN, Tonstad S. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis. 2004;23(8):625-30.
6. Khalsa A, Karim R, Mack WJ, Minkoff H, Cohen M, Young M, et al. Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study. AIDS. 2007;21(18):2539-41.
7. Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS. 2006;20(7):1019-26.
8. Palacios R, Santos J, García A, Castells E, González M, Ruiz J, et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients: a prospective study in a cohort of naive patients. HIV Med. 2006;7(1):10-5.
9. Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD. Data Collection of Adverse events of anti-HIV Drugs Study Group. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther. 2005;10(7):811-23.
10. Magalhães MG, Greenberg B, Hansen H, Glick M. Comorbidities in older patients with HIV: a retrospective study. J Am Dent Assoc. 2007;138(11):1468-75.
11. Chobanian AV, Bakris, GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52.
12. International Physical Activity Questionnaire, IPAQ. Guidelines for data processing and analysis of the International Physical Activity Questionnaire - Short and Long Forms. 2005. [acesso em 2009 abr 01]. Disponível em: http://www.ipaq.ki.se/scoring.pdf.
13. Zar JH. Biostatistical analysis. 3rd ed. New Jersey: Prentice Hall; 1996.
14. Passos VMA, Assis TD, Barreto SM. Hypertension in Brazil: estimates from population-based prevalence studies. Epidemiologia e Serviços de Saúde. 2006;15(1):35-45.
15. Sociedade Brasileira de Cardiologia. ATLAS, Corações do Brasil: v. 1. [acesso em 2009 abr 01]. Disponível em http://prevencao. cardiol.br/campanhas/coracoesdobrasil/atlas/default.asp/.
16. Coloma Conde AG, Alvarez Albarrán M, Roca-Cusachs Coll A, Domingo Pedrol P, Puig Campmany M. Prevalence of arterial hypertension and lipid profile in HIV patients. Med Clin (Barc). 2008;131(18):681-4.
17. Dusek JA, Hibberd PL, Buczynski RN, Chang, BH, Dusek KC, Johnston JM. Stress management versus lifestyle modification on systolic hypertension and medication elimination: a randomized trial. J Altern Complem Med. 2008;14(2):129-38.
18. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case control study. Lancet. 2004;364(9438):937-52.
19. Zirpoli JC. Prevalência e fatores de risco associados à angina de peito em pacientes com HIV/AIDS. [Dissertação]. Recife: Universidade Federal de Pernambuco; 2008.
20. Pupulin ART, Cassarotti D, Mosko L, Ando MH, Spack Jr M, Vieira S, et al. Prevalência de risco cardiovascular em pacientes que fazem uso de terapia anti-retroviral. Rev Bras Anal Clin. 2008;40(3):183-6.
21. Matos MFD, Souza e Silva NA, Pimenta AJ, Cunha AJ. Prevalência dos fatores de risco para doença cardiovascular em funcionários do Centro de Pesquisas da Petrobrás. Arq Bras Cardiol. 2004;82(1):1-4.
22. Jenei Z, Páll D, Katona E, Kakuk G, Polgár P. The epidemiology of hypertension and its associated risk factors in the city of Debrecen, Hungary. Public Health. 2002;116(3):138-44.
23. Sarno F, Bandoni DH, Jaime PC. Excesso de peso e hipertensão arterial em trabalhadores de empresas beneficiadas pelo Programa de Alimentação do Trabalhador (PAT). Rev Bras Epidemiol. 2008;11(3):453-62.
24. Siqueira F V, Nahas MV, Facchini LA, Silveira DS, Piccini RX, Tomasi E, et al. Aconselhamento para a prática de atividade física como estratégia de educação à saúde. Cad Saúde Pública. 2009;25(1):203-13.
25. Pickering TG. Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA. 2003;289(16):2131-2.
26. Okubo Y, Suwazono Y, Kobayashi E, Nogawa K. Alcohol consumption and blood pressure change: 5-year follow-up study of the association in normotensive workers. J Hum Hypertens. 2001;15(6):367-72.